hydroxychloroquine has been researched along with Pulmonary Disease, Chronic Obstructive in 6 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypertension and chronic obstructive pulmonary disease were also related to admission." | 1.62 | Biological markers and follow-up after discharge home of patients with COVID-19 pneumonia. ( Andrés, EM; Domínguez García, MJ; Gutiérrez Gabriel, S; Moreno García, N; Pérez Mañas, G; Silvan Domínguez, M, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 6 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lipworth, B | 1 |
| Chan, R | 1 |
| Lipworth, S | 1 |
| RuiWen Kuo, C | 1 |
| Mattioli, M | 1 |
| Fustini, E | 1 |
| Gennarini, S | 1 |
| Arıkan, F | 1 |
| Yıldız, Y | 1 |
| Ercan, T | 1 |
| Oruç, Ö | 1 |
| Akçay, S | 1 |
| Yılmaz, F | 1 |
| Toptaş, T | 1 |
| Tuğlular, T | 1 |
| Brusasco, C | 1 |
| Corradi, F | 1 |
| Di Domenico, A | 1 |
| Raggi, F | 1 |
| Timossi, G | 1 |
| Santori, G | 1 |
| Brusasco, V | 1 |
| Lee, KH | 1 |
| Kim, JS | 1 |
| Hong, SH | 1 |
| Seong, D | 1 |
| Choi, YR | 1 |
| Ahn, YT | 1 |
| Kim, KS | 1 |
| Kim, SE | 1 |
| Lee, S | 1 |
| Sim, W | 1 |
| Kim, D | 1 |
| Jun, B | 1 |
| Yang, JW | 1 |
| Yon, DK | 1 |
| Lee, SW | 1 |
| Kim, MS | 1 |
| Dragioti, E | 1 |
| Li, H | 1 |
| Jacob, L | 1 |
| Koyanagi, A | 1 |
| Abou Ghayda, R | 1 |
| Shin, JI | 1 |
| Smith, L | 1 |
| Gutiérrez Gabriel, S | 1 |
| Domínguez García, MJ | 1 |
| Pérez Mañas, G | 1 |
| Moreno García, N | 1 |
| Silvan Domínguez, M | 1 |
| Andrés, EM | 1 |
1 review available for hydroxychloroquine and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Risk factors of COVID-19 mortality: a systematic review of current literature and lessons from recent retracted articles.
Topics: Age Factors; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Asian Peopl | 2020 |
5 other studies available for hydroxychloroquine and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Age Factors; Angiotensin-Converting Enzyme Inhi | 2020 |
Heart transplant recipient patient with COVID-19 treated with tocilizumab.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Anticoagulants; Cardiomyopathy, Dilated; C | 2020 |
Hydroxychloroquine-Associated Thrombotic Thrombocytopenic Purpura
Topics: ADAMTS13 Protein; Aged; Angiography; COVID-19; Humans; Hydroxychloroquine; Male; Plasmapheresis; Pul | 2020 |
Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure.
Topics: Adult; Aged; Aged, 80 and over; Air Filters; Algorithms; Antibodies, Monoclonal, Humanized; Antirheu | 2021 |
Biological markers and follow-up after discharge home of patients with COVID-19 pneumonia.
Topics: Adult; Aged; Antiviral Agents; Biomarkers; Comorbidity; COVID-19; COVID-19 Drug Treatment; Creatine | 2021 |